Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiaoli Peng

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Chinese Medical Journal|January 31, 2023
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective studyQiaoli Peng, Xiaoning Liu, Xian Tang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in ChinaLiqin Sun, Yun He, Liumei Xu, et al.
The Lancet Regional Health. Western Pacific|January 2, 2023
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongRunhong Zhou, Na Liu, Xin Li, et al.
Ebiomedicine|November 19, 2023
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized miceYufei Mo, Ming Yue, Lok Yan Yim, et al.
Nature Microbiology|August 16, 2017
Gut-homing Δ42PD1<sup>+</sup>Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infectionAllen Ka Loon Cheung, Hau-Yee Kwok, Yiru Huang, et al.
Ebiomedicine|December 23, 2021
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse modelsRunhong Zhou, Pui Wang, Yik-Chun Wong, et al.
Journal of Virology|March 17, 2022
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA VaccineSamantha M Y Chen, Yik Chun Wong, Lok Yan Yim, et al.
Nature Communications|June 23, 2022
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challengeBiao Zhou, Runhong Zhou, Bingjie Tang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Chinese Medical Journal|January 31, 2023
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective studyQiaoli Peng, Xiaoning Liu, Xian Tang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in ChinaLiqin Sun, Yun He, Liumei Xu, et al.
The Lancet Regional Health. Western Pacific|January 2, 2023
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongRunhong Zhou, Na Liu, Xin Li, et al.
Ebiomedicine|November 19, 2023
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized miceYufei Mo, Ming Yue, Lok Yan Yim, et al.
Nature Microbiology|August 16, 2017
Gut-homing Δ42PD1<sup>+</sup>Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infectionAllen Ka Loon Cheung, Hau-Yee Kwok, Yiru Huang, et al.
Ebiomedicine|December 23, 2021
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse modelsRunhong Zhou, Pui Wang, Yik-Chun Wong, et al.
Journal of Virology|March 17, 2022
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA VaccineSamantha M Y Chen, Yik Chun Wong, Lok Yan Yim, et al.
Nature Communications|June 23, 2022
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challengeBiao Zhou, Runhong Zhou, Bingjie Tang, et al.
Pageof 3